PRR11 is a novel gene implicated in cell cycle progression and lung cancer

Ball, 2005, Recognition of proline-rich motifs by protein–protein-interaction domains, Angewandte Chemie-International Edition in English, 44, 2852, 10.1002/anie.200400618 Bernkopf, 2008, Potential role of EPB41L3 (protein 4.1B/Dal-1) as a target for treatment of advanced prostate cancer, Expert Opinion on Therapeutic Targets, 12, 845, 10.1517/14728222.12.7.845 Bu, 2010, NFBD1/MDC1 participates in the regulation of G2/M transition in mammalian cells, Biochemical and Biophysical Research Communications, 397, 157, 10.1016/j.bbrc.2010.05.063 Cao, 2010, Prognostic significance and therapeutic implications of centromere protein F expression in human nasopharyngeal carcinoma, Molecular Cancer, 9, 237, 10.1186/1476-4598-9-237 Cayrol, 2007, The THAP-zinc finger protein THAP1 regulates endothelial cell proliferation through modulation of pRB/E2F cell-cycle target genes, Blood, 109, 584, 10.1182/blood-2006-03-012013 Collins, 2006, A small interfering RNA screen for modulators of tumor cell motility identifies MAP4K4 as a promigratory kinase, Proceedings of the National Academy of Sciences of the United States of America, 103, 3775, 10.1073/pnas.0600040103 Donadel, 1991, Identification of a novel nuclear protein synthesized in growth-arrested human hepatoblastoma HepG2 cells, European Journal of Biochemistry, 195, 723, 10.1111/j.1432-1033.1991.tb15759.x Dooley, 2011, Nuclear factor I/B is an oncogene in small cell lung cancer, Genes and Development, 25, 1470, 10.1101/gad.2046711 Futreal, 2004, A census of human cancer genes, Nature Reviews Cancer, 4, 177, 10.1038/nrc1299 Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 Israels, 2000, The cell cycle, Oncologist, 5, 510, 10.1634/theoncologist.5-6-510 Jordheim, 2011, The ribonucleotide reductase large subunit (RRM1) as a predictive factor in patients with cancer, Lancet Oncology, 12, 693, 10.1016/S1470-2045(10)70244-8 Kay, 2000, The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains, FASEB Journal, 14, 231, 10.1096/fasebj.14.2.231 Liu, 2011, ShRNA-targeted MAP4K4 inhibits hepatocellular carcinoma growth, Clinical Cancer Research, 17, 710, 10.1158/1078-0432.CCR-10-0331 Liu, 2011, Integrating multiple microarray datasets on oral squamous cell carcinoma to reveal dysregulated networks, Head Neck Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods, 25, 402, 10.1006/meth.2001.1262 Malumbres, 2003, Cell cycle dysregulation: a common motif in cancer, Progress in Cell Cycle Research, 5, 5 Pérez de Castro, 2007, A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy, Carcinogenesis, 28, 899, 10.1093/carcin/bgm019 Raponi, 2006, Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung, Cancer Research, 66, 7466, 10.1158/0008-5472.CAN-06-1191 Santarius, 2010, A census of amplified and overexpressed human cancer genes, Nature Reviews Cancer, 10, 59, 10.1038/nrc2771 Sera, 2009, Zinc-finger-based artificial transcription factors and their applications, Advanced Drug Delivery Reviews, 61, 513, 10.1016/j.addr.2009.03.012 Soumaoro, 2004, Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer, Clinical Cancer Research, 10, 8465, 10.1158/1078-0432.CCR-04-0653 Takeuchi, 2006, Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors, Journal of Clinical Oncology, 24, 1679, 10.1200/JCO.2005.03.8224 Tsai, 2010, ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction, European Journal of Cancer, 46, 1712, 10.1016/j.ejca.2010.03.018 Vincenzi, 2006, Cell cycle alterations and lung cancer, Histology and Histopathology, 21, 423 Vogelstein, 2004, Cancer genes and the pathways they control, Nature Medicine, 10, 789, 10.1038/nm1087 Whitfield, 2002, Identification of genes periodically expressed in the human cell cycle and their expression in tumors, Molecular Biology of the Cell, 13, 1977, 10.1091/mbc.02-02-0030. Wong, 2007, Protein 4.1B suppresses prostate cancer progression and metastasis, Proceedings of the National Academy of Sciences of the United States of America, 104, 12784, 10.1073/pnas.0705499104 Wright, 2003, The STE20 kinase HGK is broadly expressed in human tumor cells and can modulate cellular transformation, invasion, and adhesion, Molecular and Cellular Biology, 23, 2068, 10.1128/MCB.23.6.2068-2082.2003 Yageta, 2002, Direct association of TSLC1 and DAL-1, two distinct tumor suppressor proteins in lung cancer, Cancer Research, 62, 5129